Approval · Notice of Compliance 6288 · 2005
LEVAQUIN: Notice of Compliance 6288
Issued February 14, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6288
- Date
- February 14, 2005
- Company
- Janssen-Ortho Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage regimen for acute bacterial exacerbation of chronic bronchitis
- Therapeutic class
- Antibacterial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LEVAQUIN | Not yet assigned | — |
Medicinal ingredients
- LEVOFLOXACIN 750 MG per TAB